In a press release issued on Tuesday, the Canadian division of IBM announced the strategic partnership with the pharmaceutical company Boehringer Ingelheim in a blockchain project for the maintenance of clinical records.
According to the statement, both companies study the effectiveness of blockchain technology in the processing of clinical records for “data integrity, transparency and patient safety, in addition to reducing costs and automating processes.”
IBM Canada will provide blockchain technologies to ensure trust and transparency in the testing process. The company has experience in this field through other projects in the health field.
The pharmaceutical company Boehringer Ingelheim is focused on the research and development of therapies. By partnering with IBM, it seeks the implementation of blockchain technology in data management and advances its integration in this ecosystem, in addition to offering patients greater transparency and efficiency.
Among the applications of the blockchain in the field of health is the radiology area, where the processing of medical images and diagnostics has been improved, involving X-rays and computerized tomography.
M.Pino
Source: Cointelegraph
Receive this and all our information directly on your cell phone through our channel on Telegram:https://t.me/BitFinanceNews
